nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP2D6—Vinorelbine—ovarian cancer	0.0639	0.255	CbGbCtD
Ipratropium bromide—CYP3A4—Topotecan—ovarian cancer	0.0576	0.23	CbGbCtD
Ipratropium bromide—CYP3A4—Vinorelbine—ovarian cancer	0.0406	0.162	CbGbCtD
Ipratropium bromide—CHRM3—muscle of abdomen—ovarian cancer	0.0289	0.311	CbGeAlD
Ipratropium bromide—CYP3A4—Paclitaxel—ovarian cancer	0.0285	0.114	CbGbCtD
Ipratropium bromide—CYP2D6—Doxorubicin—ovarian cancer	0.0242	0.0964	CbGbCtD
Ipratropium bromide—CYP3A4—Docetaxel—ovarian cancer	0.0206	0.0822	CbGbCtD
Ipratropium bromide—CYP3A4—Doxorubicin—ovarian cancer	0.0154	0.0613	CbGbCtD
Ipratropium bromide—CHRM5—epithelium—ovarian cancer	0.00614	0.0663	CbGeAlD
Ipratropium bromide—SLC22A4—myometrium—ovarian cancer	0.00554	0.0598	CbGeAlD
Ipratropium bromide—SLC22A4—decidua—ovarian cancer	0.00411	0.0443	CbGeAlD
Ipratropium bromide—SLC22A4—endometrium—ovarian cancer	0.0039	0.0421	CbGeAlD
Ipratropium bromide—SLC22A5—myometrium—ovarian cancer	0.00367	0.0396	CbGeAlD
Ipratropium bromide—SLC22A4—female reproductive system—ovarian cancer	0.00323	0.0349	CbGeAlD
Ipratropium bromide—SLC22A4—bone marrow—ovarian cancer	0.00305	0.0329	CbGeAlD
Ipratropium bromide—SLC22A4—vagina—ovarian cancer	0.00292	0.0315	CbGeAlD
Ipratropium bromide—SLC22A5—uterine cervix—ovarian cancer	0.00285	0.0308	CbGeAlD
Ipratropium bromide—CHRM1—female reproductive system—ovarian cancer	0.00285	0.0308	CbGeAlD
Ipratropium bromide—SLC22A5—endometrium—ovarian cancer	0.00258	0.0279	CbGeAlD
Ipratropium bromide—CHRM3—female reproductive system—ovarian cancer	0.00255	0.0275	CbGeAlD
Ipratropium bromide—CHRM3—female gonad—ovarian cancer	0.00232	0.0251	CbGeAlD
Ipratropium bromide—SLC22A5—female reproductive system—ovarian cancer	0.00214	0.0231	CbGeAlD
Ipratropium bromide—CHRM3—testis—ovarian cancer	0.00206	0.0222	CbGeAlD
Ipratropium bromide—SLC22A5—female gonad—ovarian cancer	0.00195	0.021	CbGeAlD
Ipratropium bromide—SLC22A5—vagina—ovarian cancer	0.00193	0.0209	CbGeAlD
Ipratropium bromide—SLC22A4—lymph node—ovarian cancer	0.00189	0.0204	CbGeAlD
Ipratropium bromide—SLC22A5—testis—ovarian cancer	0.00173	0.0186	CbGeAlD
Ipratropium bromide—CYP3A4—female reproductive system—ovarian cancer	0.0014	0.0151	CbGeAlD
Ipratropium bromide—CYP2D6—female reproductive system—ovarian cancer	0.00138	0.0149	CbGeAlD
Ipratropium bromide—CYP2D6—female gonad—ovarian cancer	0.00126	0.0135	CbGeAlD
Ipratropium bromide—SLC22A5—lymph node—ovarian cancer	0.00125	0.0135	CbGeAlD
Ipratropium bromide—CYP2D6—testis—ovarian cancer	0.00111	0.012	CbGeAlD
Ipratropium bromide—Nausea—Chlorambucil—ovarian cancer	0.00111	0.00169	CcSEcCtD
Ipratropium bromide—Vision blurred—Paclitaxel—ovarian cancer	0.00111	0.00169	CcSEcCtD
Ipratropium bromide—Visual impairment—Docetaxel—ovarian cancer	0.0011	0.00168	CcSEcCtD
Ipratropium bromide—Dizziness—Topotecan—ovarian cancer	0.0011	0.00168	CcSEcCtD
Ipratropium bromide—Tremor—Paclitaxel—ovarian cancer	0.0011	0.00168	CcSEcCtD
Ipratropium bromide—Angioedema—Paclitaxel—ovarian cancer	0.00107	0.00164	CcSEcCtD
Ipratropium bromide—Eye disorder—Docetaxel—ovarian cancer	0.00107	0.00163	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Docetaxel—ovarian cancer	0.00106	0.00162	CcSEcCtD
Ipratropium bromide—Flushing—Docetaxel—ovarian cancer	0.00106	0.00162	CcSEcCtD
Ipratropium bromide—Vomiting—Topotecan—ovarian cancer	0.00106	0.00161	CcSEcCtD
Ipratropium bromide—Rash—Topotecan—ovarian cancer	0.00105	0.0016	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00105	0.0016	CcSEcCtD
Ipratropium bromide—Dermatitis—Topotecan—ovarian cancer	0.00105	0.0016	CcSEcCtD
Ipratropium bromide—Headache—Topotecan—ovarian cancer	0.00104	0.00159	CcSEcCtD
Ipratropium bromide—Palpitations—Paclitaxel—ovarian cancer	0.00104	0.00158	CcSEcCtD
Ipratropium bromide—Vomiting—Melphalan—ovarian cancer	0.00104	0.00158	CcSEcCtD
Ipratropium bromide—Immune system disorder—Docetaxel—ovarian cancer	0.00103	0.00157	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Docetaxel—ovarian cancer	0.00103	0.00157	CcSEcCtD
Ipratropium bromide—Rash—Melphalan—ovarian cancer	0.00103	0.00157	CcSEcCtD
Ipratropium bromide—Dermatitis—Melphalan—ovarian cancer	0.00103	0.00157	CcSEcCtD
Ipratropium bromide—Cough—Paclitaxel—ovarian cancer	0.00103	0.00156	CcSEcCtD
Ipratropium bromide—Asthenia—Vinorelbine—ovarian cancer	0.00102	0.00156	CcSEcCtD
Ipratropium bromide—Hypertension—Paclitaxel—ovarian cancer	0.00101	0.00155	CcSEcCtD
Ipratropium bromide—Pruritus—Vinorelbine—ovarian cancer	0.00101	0.00154	CcSEcCtD
Ipratropium bromide—Chest pain—Paclitaxel—ovarian cancer	0.001	0.00152	CcSEcCtD
Ipratropium bromide—Myalgia—Paclitaxel—ovarian cancer	0.001	0.00152	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000993	0.00151	CcSEcCtD
Ipratropium bromide—Nausea—Topotecan—ovarian cancer	0.00099	0.00151	CcSEcCtD
Ipratropium bromide—Dry mouth—Paclitaxel—ovarian cancer	0.000978	0.00149	CcSEcCtD
Ipratropium bromide—Diarrhoea—Vinorelbine—ovarian cancer	0.000975	0.00149	CcSEcCtD
Ipratropium bromide—Dysgeusia—Docetaxel—ovarian cancer	0.000975	0.00149	CcSEcCtD
Ipratropium bromide—Nausea—Melphalan—ovarian cancer	0.000969	0.00148	CcSEcCtD
Ipratropium bromide—Influenza—Epirubicin—ovarian cancer	0.000964	0.00147	CcSEcCtD
Ipratropium bromide—Asthma—Epirubicin—ovarian cancer	0.000964	0.00147	CcSEcCtD
Ipratropium bromide—Dysphagia—Epirubicin—ovarian cancer	0.000964	0.00147	CcSEcCtD
Ipratropium bromide—Back pain—Docetaxel—ovarian cancer	0.000963	0.00147	CcSEcCtD
Ipratropium bromide—Oedema—Paclitaxel—ovarian cancer	0.000959	0.00146	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000959	0.00146	CcSEcCtD
Ipratropium bromide—Infection—Paclitaxel—ovarian cancer	0.000953	0.00145	CcSEcCtD
Ipratropium bromide—Dizziness—Vinorelbine—ovarian cancer	0.000943	0.00144	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Paclitaxel—ovarian cancer	0.00094	0.00143	CcSEcCtD
Ipratropium bromide—Tachycardia—Paclitaxel—ovarian cancer	0.000936	0.00143	CcSEcCtD
Ipratropium bromide—Skin disorder—Paclitaxel—ovarian cancer	0.000931	0.00142	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—ovarian cancer	0.000927	0.00141	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000927	0.00141	CcSEcCtD
Ipratropium bromide—Vomiting—Vinorelbine—ovarian cancer	0.000906	0.00138	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—ovarian cancer	0.000901	0.00137	CcSEcCtD
Ipratropium bromide—Rash—Vinorelbine—ovarian cancer	0.000899	0.00137	CcSEcCtD
Ipratropium bromide—Dermatitis—Vinorelbine—ovarian cancer	0.000898	0.00137	CcSEcCtD
Ipratropium bromide—Hypotension—Paclitaxel—ovarian cancer	0.000896	0.00136	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000896	0.00136	CcSEcCtD
Ipratropium bromide—Headache—Vinorelbine—ovarian cancer	0.000893	0.00136	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—ovarian cancer	0.000892	0.00136	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—ovarian cancer	0.000892	0.00136	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—ovarian cancer	0.000892	0.00136	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—ovarian cancer	0.000891	0.00136	CcSEcCtD
Ipratropium bromide—Palpitations—Docetaxel—ovarian cancer	0.00088	0.00134	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000874	0.00133	CcSEcCtD
Ipratropium bromide—Cough—Docetaxel—ovarian cancer	0.000869	0.00132	CcSEcCtD
Ipratropium bromide—Insomnia—Paclitaxel—ovarian cancer	0.000867	0.00132	CcSEcCtD
Ipratropium bromide—Paraesthesia—Paclitaxel—ovarian cancer	0.000861	0.00131	CcSEcCtD
Ipratropium bromide—Hypertension—Docetaxel—ovarian cancer	0.00086	0.00131	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—ovarian cancer	0.000858	0.00131	CcSEcCtD
Ipratropium bromide—Dyspnoea—Paclitaxel—ovarian cancer	0.000855	0.0013	CcSEcCtD
Ipratropium bromide—Somnolence—Paclitaxel—ovarian cancer	0.000852	0.0013	CcSEcCtD
Ipratropium bromide—Chest pain—Docetaxel—ovarian cancer	0.000848	0.00129	CcSEcCtD
Ipratropium bromide—Myalgia—Docetaxel—ovarian cancer	0.000848	0.00129	CcSEcCtD
Ipratropium bromide—Nausea—Vinorelbine—ovarian cancer	0.000847	0.00129	CcSEcCtD
Ipratropium bromide—Dyspepsia—Paclitaxel—ovarian cancer	0.000844	0.00129	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000843	0.00128	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000842	0.00128	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—ovarian cancer	0.000838	0.00128	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—ovarian cancer	0.000835	0.00127	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—ovarian cancer	0.000835	0.00127	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—ovarian cancer	0.000834	0.00127	CcSEcCtD
Ipratropium bromide—Dry mouth—Docetaxel—ovarian cancer	0.000829	0.00126	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000829	0.00126	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000828	0.00126	CcSEcCtD
Ipratropium bromide—Fatigue—Paclitaxel—ovarian cancer	0.000827	0.00126	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—ovarian cancer	0.000824	0.00126	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—ovarian cancer	0.000824	0.00126	CcSEcCtD
Ipratropium bromide—Pain—Paclitaxel—ovarian cancer	0.00082	0.00125	CcSEcCtD
Ipratropium bromide—Constipation—Paclitaxel—ovarian cancer	0.00082	0.00125	CcSEcCtD
Ipratropium bromide—Oedema—Docetaxel—ovarian cancer	0.000813	0.00124	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Docetaxel—ovarian cancer	0.000813	0.00124	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—ovarian cancer	0.000811	0.00123	CcSEcCtD
Ipratropium bromide—Infection—Docetaxel—ovarian cancer	0.000807	0.00123	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—ovarian cancer	0.000806	0.00123	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Docetaxel—ovarian cancer	0.000797	0.00121	CcSEcCtD
Ipratropium bromide—Tachycardia—Docetaxel—ovarian cancer	0.000793	0.00121	CcSEcCtD
Ipratropium bromide—Skin disorder—Docetaxel—ovarian cancer	0.000789	0.0012	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000784	0.00119	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00078	0.00119	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—ovarian cancer	0.000776	0.00118	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—ovarian cancer	0.000775	0.00118	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—ovarian cancer	0.000774	0.00118	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—ovarian cancer	0.000773	0.00118	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—ovarian cancer	0.000773	0.00118	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—ovarian cancer	0.000772	0.00118	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—ovarian cancer	0.000768	0.00117	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—ovarian cancer	0.000766	0.00117	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—ovarian cancer	0.000762	0.00116	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000762	0.00116	CcSEcCtD
Ipratropium bromide—Urticaria—Paclitaxel—ovarian cancer	0.000762	0.00116	CcSEcCtD
Ipratropium bromide—Hypotension—Docetaxel—ovarian cancer	0.000759	0.00116	CcSEcCtD
Ipratropium bromide—Abdominal pain—Paclitaxel—ovarian cancer	0.000758	0.00115	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—ovarian cancer	0.000756	0.00115	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—ovarian cancer	0.00075	0.00114	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—ovarian cancer	0.000746	0.00114	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—ovarian cancer	0.000744	0.00113	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00074	0.00113	CcSEcCtD
Ipratropium bromide—Insomnia—Docetaxel—ovarian cancer	0.000735	0.00112	CcSEcCtD
Ipratropium bromide—Paraesthesia—Docetaxel—ovarian cancer	0.00073	0.00111	CcSEcCtD
Ipratropium bromide—Dyspnoea—Docetaxel—ovarian cancer	0.000725	0.0011	CcSEcCtD
Ipratropium bromide—Somnolence—Docetaxel—ovarian cancer	0.000723	0.0011	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—ovarian cancer	0.000721	0.0011	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—ovarian cancer	0.000719	0.0011	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—ovarian cancer	0.000718	0.00109	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—ovarian cancer	0.000716	0.00109	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—ovarian cancer	0.000716	0.00109	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—ovarian cancer	0.000716	0.00109	CcSEcCtD
Ipratropium bromide—Dyspepsia—Docetaxel—ovarian cancer	0.000715	0.00109	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—ovarian cancer	0.000714	0.00109	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00071	0.00108	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—ovarian cancer	0.000709	0.00108	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000706	0.00108	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000705	0.00107	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000702	0.00107	CcSEcCtD
Ipratropium bromide—Fatigue—Docetaxel—ovarian cancer	0.000701	0.00107	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—ovarian cancer	0.0007	0.00107	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—ovarian cancer	0.000697	0.00106	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—ovarian cancer	0.000695	0.00106	CcSEcCtD
Ipratropium bromide—Constipation—Docetaxel—ovarian cancer	0.000695	0.00106	CcSEcCtD
Ipratropium bromide—Pain—Docetaxel—ovarian cancer	0.000695	0.00106	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—ovarian cancer	0.000688	0.00105	CcSEcCtD
Ipratropium bromide—Asthenia—Paclitaxel—ovarian cancer	0.000688	0.00105	CcSEcCtD
Ipratropium bromide—Pruritus—Paclitaxel—ovarian cancer	0.000678	0.00103	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—ovarian cancer	0.000667	0.00102	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—ovarian cancer	0.000666	0.00101	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000665	0.00101	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000663	0.00101	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—ovarian cancer	0.000663	0.00101	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—ovarian cancer	0.000662	0.00101	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—ovarian cancer	0.000659	0.001	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—ovarian cancer	0.000658	0.001	CcSEcCtD
Ipratropium bromide—Diarrhoea—Paclitaxel—ovarian cancer	0.000656	0.000999	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—ovarian cancer	0.000652	0.000994	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—ovarian cancer	0.00065	0.00099	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—ovarian cancer	0.000645	0.000982	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000643	0.00098	CcSEcCtD
Ipratropium bromide—Abdominal pain—Docetaxel—ovarian cancer	0.000642	0.000979	CcSEcCtD
Ipratropium bromide—Dizziness—Paclitaxel—ovarian cancer	0.000634	0.000966	CcSEcCtD
Ipratropium bromide—Vision blurred—Epirubicin—ovarian cancer	0.000633	0.000964	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—ovarian cancer	0.000612	0.000933	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—ovarian cancer	0.00061	0.000929	CcSEcCtD
Ipratropium bromide—Vomiting—Paclitaxel—ovarian cancer	0.00061	0.000929	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—ovarian cancer	0.000609	0.000927	CcSEcCtD
Ipratropium bromide—Rash—Paclitaxel—ovarian cancer	0.000605	0.000921	CcSEcCtD
Ipratropium bromide—Dermatitis—Paclitaxel—ovarian cancer	0.000604	0.00092	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—ovarian cancer	0.000604	0.00092	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—ovarian cancer	0.000601	0.000916	CcSEcCtD
Ipratropium bromide—Headache—Paclitaxel—ovarian cancer	0.000601	0.000915	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Docetaxel—ovarian cancer	0.000599	0.000912	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—ovarian cancer	0.000594	0.000904	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—ovarian cancer	0.000586	0.000893	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—ovarian cancer	0.000586	0.000892	CcSEcCtD
Ipratropium bromide—Asthenia—Docetaxel—ovarian cancer	0.000583	0.000888	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—ovarian cancer	0.00058	0.000883	CcSEcCtD
Ipratropium bromide—Pruritus—Docetaxel—ovarian cancer	0.000575	0.000876	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—ovarian cancer	0.000572	0.000871	CcSEcCtD
Ipratropium bromide—Chest pain—Epirubicin—ovarian cancer	0.000572	0.000871	CcSEcCtD
Ipratropium bromide—Nausea—Paclitaxel—ovarian cancer	0.00057	0.000868	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000568	0.000865	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—ovarian cancer	0.000559	0.000852	CcSEcCtD
Ipratropium bromide—Diarrhoea—Docetaxel—ovarian cancer	0.000556	0.000847	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—ovarian cancer	0.000549	0.000837	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000548	0.000835	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—ovarian cancer	0.000548	0.000835	CcSEcCtD
Ipratropium bromide—Infection—Epirubicin—ovarian cancer	0.000545	0.00083	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—ovarian cancer	0.000542	0.000826	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—ovarian cancer	0.000538	0.000819	CcSEcCtD
Ipratropium bromide—Dizziness—Docetaxel—ovarian cancer	0.000537	0.000819	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—ovarian cancer	0.000537	0.000817	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—ovarian cancer	0.000535	0.000815	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—ovarian cancer	0.000532	0.000811	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—ovarian cancer	0.00053	0.000807	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—ovarian cancer	0.000529	0.000806	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—ovarian cancer	0.000529	0.000806	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000525	0.0008	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—ovarian cancer	0.000517	0.000788	CcSEcCtD
Ipratropium bromide—Vomiting—Docetaxel—ovarian cancer	0.000517	0.000787	CcSEcCtD
Ipratropium bromide—Rash—Docetaxel—ovarian cancer	0.000512	0.000781	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—ovarian cancer	0.000512	0.00078	CcSEcCtD
Ipratropium bromide—Dermatitis—Docetaxel—ovarian cancer	0.000512	0.00078	CcSEcCtD
Ipratropium bromide—Headache—Docetaxel—ovarian cancer	0.000509	0.000776	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000507	0.000773	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—ovarian cancer	0.000507	0.000773	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—ovarian cancer	0.000504	0.000768	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000499	0.000761	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000497	0.000758	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—ovarian cancer	0.000496	0.000755	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—ovarian cancer	0.000495	0.000754	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—ovarian cancer	0.000493	0.000751	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—ovarian cancer	0.000492	0.00075	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00049	0.000747	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—ovarian cancer	0.000489	0.000744	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—ovarian cancer	0.000487	0.000742	CcSEcCtD
Ipratropium bromide—Nausea—Docetaxel—ovarian cancer	0.000483	0.000735	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—ovarian cancer	0.000483	0.000735	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—ovarian cancer	0.000474	0.000722	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000473	0.000721	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—ovarian cancer	0.000473	0.00072	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—ovarian cancer	0.000469	0.000714	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—ovarian cancer	0.000469	0.000714	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000462	0.000704	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—ovarian cancer	0.000459	0.000699	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—ovarian cancer	0.000455	0.000694	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—ovarian cancer	0.000452	0.000689	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—ovarian cancer	0.000451	0.000687	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000448	0.000683	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—ovarian cancer	0.000446	0.00068	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000438	0.000667	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—ovarian cancer	0.000437	0.000666	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—ovarian cancer	0.000435	0.000663	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—ovarian cancer	0.000434	0.000661	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—ovarian cancer	0.000434	0.000661	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—ovarian cancer	0.000433	0.00066	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000415	0.000632	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—ovarian cancer	0.000404	0.000615	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—ovarian cancer	0.000403	0.000614	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—ovarian cancer	0.000401	0.000611	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—ovarian cancer	0.000393	0.000599	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—ovarian cancer	0.000388	0.000591	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—ovarian cancer	0.000375	0.000571	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000374	0.000569	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—ovarian cancer	0.000364	0.000554	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—ovarian cancer	0.000363	0.000552	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—ovarian cancer	0.000359	0.000547	CcSEcCtD
Ipratropium bromide—Vomiting—Epirubicin—ovarian cancer	0.000349	0.000531	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—ovarian cancer	0.000347	0.000529	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—ovarian cancer	0.000346	0.000527	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—ovarian cancer	0.000345	0.000526	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—ovarian cancer	0.000343	0.000523	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—ovarian cancer	0.000335	0.000511	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—ovarian cancer	0.000326	0.000496	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—ovarian cancer	0.000322	0.000491	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—ovarian cancer	0.00032	0.000487	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—ovarian cancer	0.00032	0.000487	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—ovarian cancer	0.000318	0.000484	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—ovarian cancer	0.000301	0.000459	CcSEcCtD
